Friday, March 11, 2022 10:49:25 AM
Not much demand for the weak shares. Now it's in the red. Weak as can be.
What a shame. Let me reiterate that I predicted, and rightly so, this would go back into the trips after all the hype was done.
My general thesis has always been correct even with all the hate I have gotten.
Reality is reality. Facts are facts.
And yet many still don't want to face the reality of who runs this company and his past failures.
If one can profit off the small pops, then I salute that person. But that's all this stock is good for. It has no future.
That's undeniable.
What a shame. Let me reiterate that I predicted, and rightly so, this would go back into the trips after all the hype was done.
My general thesis has always been correct even with all the hate I have gotten.
Reality is reality. Facts are facts.
And yet many still don't want to face the reality of who runs this company and his past failures.
If one can profit off the small pops, then I salute that person. But that's all this stock is good for. It has no future.
That's undeniable.
FACTS are stubborn things
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
